Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device.

Transcatheter aortic valve implantation (TAVI) has demonstrated the feasibility of treating valvular heart disease with transcatheter therapy. On the back of this success, various transcatheter concepts are being evaluated to treat other valvular disease, especially mitral regurgitation (MR). The concepts currently approved to treat MR replicate surgical mitral valve repair. However, most of them cannot eliminate MR completely. Similar to TAVI, a transcatheter mitral valve implantation may provide a valuable alternative. The FORTIS transcatheter mitral valve (Edwards Lifesciences, Irvine, CA, USA) is a self-expanding device implanted via a transapical approach. We describe our experience and early results in the first five patients treated on compassionate grounds. We also describe the details of the device, selection criteria and technical details of implantation.

[1]  D. Adams,et al.  Relationship among surgical volume, repair quality, and perioperative outcomes for repair of mitral insufficiency in a mitral valve reference center. , 2014, The Journal of thoracic and cardiovascular surgery.

[2]  E. Tuzcu,et al.  MitraClip for severe symptomatic mitral regurgitation in patients at high surgical risk , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  O. Morel,et al.  Mitral valve surgery for transient severe mitral regurgitation: an alternative to medical treatment? , 2014, International journal of cardiology.

[4]  M. Solinas,et al.  Mitral valve repair versus replacement in patients with ischaemic mitral regurgitation and depressed ejection fraction: risk factors for early and mid-term mortality†. , 2014, Interactive cardiovascular and thoracic surgery.

[5]  P. Grayburn,et al.  Ischemic and Functional Mitral Regurgitation in Heart Failure: Natural History and Treatment , 2014, Current Cardiology Reports.

[6]  Francesco Maisano,et al.  Percutaneous Transcatheter Mitral Valve Replacement: An Overview of Devices in Preclinical and Early Clinical Evaluation , 2014, Circulation. Cardiovascular interventions.

[7]  O. Alfieri,et al.  Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the TACT Trial (Transapical Artificial Chordae Tendinae) proof of concept. , 2014, Journal of the American College of Cardiology.

[8]  Andrew B Goldstone,et al.  Minimally invasive surgical treatment of valvular heart disease. , 2014, Seminars in thoracic and cardiovascular surgery.

[9]  Joshua N. Baker,et al.  Outcomes of Transcatheter and Surgical Aortic Valve Replacement in High-Risk Patients With Aortic Stenosis and Left Ventricular Dysfunction: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort A) , 2013, Circulation. Cardiovascular interventions.

[10]  D. Adams,et al.  Video-atlas on minimally invasive mitral valve surgery-The David Adams technique. , 2013, Annals of cardiothoracic surgery.

[11]  E. Foster,et al.  4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. , 2013, Journal of the American College of Cardiology.

[12]  R. Lange,et al.  Transapical aortic valve implantation: mid-term outcome from the SOURCE registry. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  Alain Cribier,et al.  Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. , 2012, European heart journal.

[14]  R. Lange,et al.  The German Aortic Valve Registry (GARY): A Nationwide Registry for Patients Undergoing Invasive Therapy for Severe Aortic Valve Stenosis , 2012, Thoracic and Cardiovascular Surgeon.

[15]  I. Palacios,et al.  Percutaneous techniques for mitral valve disease. , 2010, Cardiology clinics.

[16]  P. Ponikowski,et al.  EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. , 2006, European heart journal.

[17]  Ludwig K von Segesser,et al.  Double-crowned valved stents for off-pump mitral valve replacement. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  Timothy J Gardner,et al.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. , 2014, The New England journal of medicine.

[19]  C. Ruiz,et al.  Percutaneous transcatheter mitral valve repair: a classification of the technology. , 2011, JACC. Cardiovascular interventions.